- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04924959
Construction and Validation of Risk Prediction Model for PICC Catheter Displacement
June 10, 2021 updated by: Second Affiliated Hospital, School of Medicine, Zhejiang University
The occurrence of PICC catheter displacement is caused by many factors.
In order to predict the risk of PICC and early warn high-risk patients, this study prospectively included patients with PICC catheter in a three Grade-A hospitals in June 2019, analyzed a variety of related factors, built a scientific and effective risk prediction model of PICC catheter displacement, and verified the goodness of fit and differential validity of the model.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
663
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Zhejiang
-
Hangzhou, Zhejiang, China, 310000
- 2nd Affilicated Hospital, School of Medicine, Zhejiang University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Cancer patients with PICC
Description
Inclusion Criteria:
- Patients with PICC
Exclusion Criteria:
- Patients with primary ectopia during PICC catheterization
- Patients with secondary ectopic adjusting length of catheter exposure
- Patients with mental illness and cognitive impairment
- Patients with incomplete clinical data
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Modeling Group
|
Using logistic regression analysis to analyze the independent risk factors of PICC catheter displacement
|
Validation Group
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Prediction Model of PICC catheter displacement
Time Frame: 3 years
|
A mathematical model for predicting PICC catheter displacement
|
3 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
June 27, 2019
Primary Completion (ANTICIPATED)
June 30, 2022
Study Completion (ANTICIPATED)
October 30, 2022
Study Registration Dates
First Submitted
June 10, 2021
First Submitted That Met QC Criteria
June 10, 2021
First Posted (ACTUAL)
June 14, 2021
Study Record Updates
Last Update Posted (ACTUAL)
June 14, 2021
Last Update Submitted That Met QC Criteria
June 10, 2021
Last Verified
June 1, 2021
More Information
Terms related to this study
Other Study ID Numbers
- 2019-205
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer Patients With PICC
-
Jena University HospitalCompleted
-
Universitaire Ziekenhuizen KU LeuvenCompletedPatients With Any Condition Who Need a PICC for IV TherapyBelgium
-
National Cancer Center, KoreaCompletedPatients Cannulated With Both PICC and CICC. | The Rapidly Fluctuating Hemodynamics During LT.Korea, Republic of
-
Angiodynamics, Inc.TerminatedPatients Indicated for a PICC for Any Medical ConditionSwitzerland, United States, Canada
-
Philogen S.p.A.TerminatedPatients With CancerItaly, United Kingdom
-
Centre Francois BaclesseRecruitingPatients With CancerFrance
-
Elevar TherapeuticsBukwang Pharmaceutical, Co., Ltd.CompletedCancer Patients With Solid TumorsKorea, Republic of, United States
-
Hospices Civils de LyonUnknown
-
Greater Baltimore Medical CenterWithdrawnCancer | Patients With Clinical and Environmental Risk Factors for Cancer | Patients With a Suspected or Confirmed Diagnosis of CancerUnited States
-
Centre Francois BaclesseCompletedPatients With Cancer Who Start Immunotherapy | All NeoplasmsFrance
Clinical Trials on Logistic Regression Analysis
-
Versailles HospitalCompleted
-
Dr. Negrin University HospitalCardiff University; Unity Health Toronto; Leiden University Medical CenterCompletedAcute Respiratory Distress SyndromeSpain, United Kingdom
-
Dr. Negrin University HospitalUnity Health TorontoCompleted
-
Kaiser PermanenteThe Permanente Medical GroupWithdrawnColorectal Cancer | Colorectal Adenoma | Colorectal Polyp | Neoplasm, ColorectalUnited States
-
Dr. Negrin University HospitalActive, not recruitingAcute Hypoxemic Respiratory FailureSpain
-
Academisch Medisch Centrum - Universiteit van Amsterdam...CompletedColorectal Neoplasms | Colorectal Cancer | Colorectal Adenoma | Colorectal Carcinoma | Colorectal Adenoma and CarcinomaNetherlands
-
Dr Adnan AghaAbu Dhabi Health Services CompanyRecruitingCOVID-19United Arab Emirates
-
Johnson & Johnson Consumer Inc. (J&JCI)CompletedSkin Care | Skin | Skin CreamUnited States
-
Kaiser PermanenteUniversity of Colorado, DenverCompletedCommunicable DiseaseUnited States
-
Indonesia UniversityCompleted